Syneos Health launched Ventilator Initiative to raise awareness of bridging option to address ventilator shortage
On Mar. 27, 2020, Syneos Health announced the launch of a Ventilator Initiative. This multi-disciplinary initiative is designed…
COVID-19 | Diagnostics | Medical Device | Therapeutics | WHO
WHO Director-General calls on G20 to fight, unite, and ignite against COVID-19
On Mar. 26, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), addressed Heads of…
Amyris launched hand sanitizer and receives initial positive result for vaccine adjuvant
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
iBio announced advancement of COVID-19 vaccine program
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
iBio supporting AzarGen Biotechnologies’ development of a Rituximab biosimilar at Bryan, Texas facility
On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed…
Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
Biotechnology | COVID-19 | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
Life sciences companies commit to fight against COVID-19 pandemic with Bill & Melinda Gates Foundation
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
Partner Therapeutics announced initiation of clinical trial to evaluate Leukine in patients with COVID-19
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
Agriculture | Biotechnology | Disease | Therapeutics | USDA | Veterinary
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
Cumberland Pharma Announced Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
Emory’s DRIVE, Ridgeback partnered for drug versus coronavirus
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…